Evidence map›Paper›PMID 18377790›Full record

ArticleCurrent atherosclerosis reports2007

Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models.

J Mark Brown, Gregory S Shelness, Lawrence L Rudel

Abstract read
PubMed Publisher
In one paragraph

Article in Current atherosclerosis reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The role of nutraceutical supplements in the treatment of dyslipidemia.Journal of clinical hypertension (Greenwich, Conn.) · 2012
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Nutrigenomics in cardiovascular medicine.Circulation. Cardiovascular genetics · 2009
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J Mark BrownWake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1040, USA.
Gregory S Shelness
Lawrence L Rudel
Wake Forest University · US

Funding

TISSUE CULTURE COREP01HL049373 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SHELNESS, GREGORY S · 1993 to 2012
$23.8M
Mechanisms Regulating Non-biliary Fecal Sterol LossR00HL096166 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BROWN, JONATHAN MARK · 2011 to 2013
$733k
NHLBI NIH HHS P01-HL49373NHLBI NIH HHS R00 HL096166
6 · The paper itself

Abstract

A substantial body of epidemiologic data has shed light on the potential protective effects of the Mediterranean diet against atherosclerosis in humans. Many believe the reason the Mediterranean diet is atheroprotective is the elevated consumption of olive oil, an oil poor in saturated fatty acids (SFA) and highly enriched in monounsaturated fatty acids (MUFA). Based on human feeding studies, the American Heart Association and the US Food and Drug Administration have advocated for the consumption of MUFA as a more healthy replacement for SFA. However, using experimental animal models in which extent of atherosclerosis can be directly measured following dietary intervention, it has been demonstrated that MUFA-enriched diets are not atheroprotective when compared with SFA-enriched diets. Hence, the current body of experimental evidence refutes the idea that MUFAs per se are atheroprotective; therefore much additional work is needed to determine which aspects of the Mediterranean diet are indeed heart healthy.

Indexed as

Diet, MediterraneanAnimalsAtherosclerosisDietDisease Models, AnimalFatty AcidsFatty Acids, MonounsaturatedHumansLife StyleLiverOlive OilPlant OilsSterol O-AcyltransferaseSterol O-Acyltransferase 2Fatty AcidsFatty Acids, MonounsaturatedOlive OilPlant OilsSterol O-AcyltransferaseSterol O-Acyltransferase 2

Identifiers

PMID18377790
OpenAlexW2087460404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.